OakChart

Regencell Bioscience Holdings Ltd

RGCHealthcare·Drug Manufacturers - Specialty & Generic·Hong Kong·Mid·NASD·Nov 13 • 7:16 AM ET

5.14+0.01 (0.29%)
2026-11-13 13:16 CET
Market cap
$2.55B
Revenue, TTM
0.00 USD m
Net income, TTM
-11.70 USD m
Free cash flow, TTM
-7.70 USD m
EPS diluted, TTM
-0.02
Price / earnings
-
Compare

Price

RGC against its 20, 50 and 200-day averages
Terms2050200
Patternshover a marker to name it
RS 1910.0020.0030.001.3M2.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RGCclose 5.1420-day 6.9450-day 6.80200-day 15.985.14

92.6% under the 52-week high of 69.00 on 8 Jan 2026. 52-week low 4.51 on 17 Jul 2026. Last 15 sessions, 57.5% high to low

Volume 0.18× normal · the line is the 50-bar volume average

Setup. RS line 19
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50% — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 2 of 5 — fails: Return on Equity: Over +15% — not on the tape: Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Ownership: Over 30%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K

Profile

RGC
52-week range, 1% of the way up
4.5169.00

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Employees10
IPOJul 16, 2021
Beta1.75
ATR, 14d0.75
Rel volume0.18
Short float0.62%
Insider own88.68%
Inst own0.26%

Snapshot

6 groups

Valuation

Index-
Market Cap$2.55B
Enterprise Value2.53B
Income-11.70M
Sales0.00M
Book / share0.03
Cash / share0.03
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees10
IPOJul 16, 2021

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales-
Price / book190.94
Price / cash179.62
Price / free cash flow-
Value / cash profit-
Value / sales-
Quick Ratio10.77
Current Ratio10.77
Debt / equity0.02
Long-term debt / equity0.00
Options and shortYes / Yes

Earnings

Earnings / share-0.02
Earnings next year-
Earnings next quarter-
Earnings this year-
Earnings next year-
Earnings growth, 5 years-
Past earnings growth-25.82% -53.29%
Past sales growth- -
Earnings vs last year-227.78%
Sales vs last year-
Earnings vs last quarter-268.57%
Sales vs last quarter-
Earnings-
Surprise- -

Ownership

Insiders own88.68%
Insider trades0.00%
Institutions own0.26%
Institution trades63.18%
Return on assets-114.25%
Return on equity-128.52%
Return on capital-87.27%
Gross Margin-
Operating margin-
Profit Margin-
20-day average-25.92%
50-day average-24.38%
200-day average-67.84%

Technical

Shares out495.88M
Shares floating56.15M
Short / float0.62%
Short ratio1.46
Short interest0.35M
52-week high69.00 -92.6%
52-week low4.51 +14.0%
Volatility8.71% 14.80%
Average range0.75
Strength index35.93
Market sensitivity1.75
Relative volume0.18
Avg Volume239.91K
Volume2,142

Performance

Perf Week-2.47%
Perf Month-46.01%
Perf Quarter-3.93%
Perf Half Y-82.02%
Perf YTD-75.52%
Perf Year-60.46%
Perf 3Y1210.87%
Perf 5Y676.93%
Perf 10Y-
Recommendation-
Target Price-
Prev Close5.12
Price5.14
Change %0.29%

Peers

Mkt cap
TickerCompanyMkt cap
SUPNSupernus Inc6.07B
AYTUAytu BioPharma Inc19.45M
SXTCChina SXT Pharmaceuticals Inc2.03M
UPCUniverse Pharmaceuticals INC7.69M
HCMHUTCHMED (China) Limited ADR2.59B
ACADAcadia Pharmaceuticals Inc3.13B
CINGCingulate Inc65.29M
CPHIChina Pharma Holdings Inc21.53M
AVXLAnavex Life Sciences Corp93.62M
ZVRAZevra Therapeutics Inc609.92M

Held by

AUM
TickerCompanyAUM
ONEQFidelity Nasdaq Composite Index ETFAUM: 10.51B
GXCState Street SPDR S&P China ETFAUM: 439.74M

News

latest 14 of 126

Quarterly earnings

actual against estimate

No quarterly earnings.

Annual earnings

No annual earnings.

Estimate revisions

Latest snapshot of each period and type.

No estimate revisions.

Estimate history

Annual
Metric20192020202120222023202420252026
EPS per share-0.001-0.002-0.003-0.015-0.012-0.009-0.007-0.024
Sales USD millions00000000
Shares million shares480480480494494494494496

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2026FY6/30/20262025FY6/30/20252024FY6/30/20242023FY6/30/20232022FY6/30/20222021FY6/30/20212020FY6/30/20202019FY6/30/2019
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.400.40+2.6%0.39-48.0%0.75-2.6%0.77+28.3%0.60+1900.0%0.03+200.0%0.010.00
Gross Profit-0.40-0.40-0.39-0.75-0.77-0.60-0.03-0.010.00
Selling, General and Administrative Excl. Other11.3211.32+234.9%3.38-15.3%3.99-27.5%5.50-21.5%7.01+419.3%1.35+68.8%0.80+105.1%0.39
Research and Development1.301.30+36.8%0.95-11.2%1.07-32.3%1.58-37.1%2.51+470.5%0.44+12.8%0.39+69.6%0.23
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-11.72-11.72-3.77-4.74-6.27-7.62-1.38-0.81-0.39
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.000.00
Net Income Before Taxes-11.70-11.70-3.58-4.36-6.06-7.59-1.35-0.81-0.39
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-11.70-11.70-3.58-4.36-6.06-7.59-1.35-0.81-0.39
Net Income From Continuing Operations-11.70-11.70-3.58-4.30-5.87-7.59-1.35-0.81-0.39
Net Income-11.70-11.70-3.58-4.30-5.87-7.59-1.35-0.81-0.39
EPS (Recurring) per share-0.02-0.02-0.01-0.01-0.01-0.02-0.00-0.00-0.00
EPS (Basic, Before Extraordinaries) per share-0.02-0.02-0.01-0.01-0.01-0.02-0.00-0.00-0.00
EPS (Diluted) per share-0.02-0.02-0.01-0.01-0.01-0.02-0.00-0.00-0.00
EBITDA-11.32-11.32-3.38-3.99-5.50-7.01-1.35-0.80-0.39
Non-Operating Income (Expense)0.020.02-89.5%0.19-48.6%0.37+76.2%0.21+950.0%0.02-33.3%0.030.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.233.23+1245.8%0.24-54.7%0.53-27.4%0.73-73.6%2.76---
Shares Outstanding million shares495.88495.88+0.3%494.490.0%494.490.0%494.490.0%494.49+2.9%480.400.0%480.400.0%480.40
Market Capitalization2,541.412,541.41-69.8%8,426.09+732603.5%1.15-85.4%7.89-33.2%11.81+9.9%10.75--

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026S26/30/20262026S112/31/20252025S26/30/20252025S112/31/20242024S26/30/20242024S112/31/20232023S26/30/20232023S112/31/2022
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.360.040.000.000.000.000.770.00
Gross Profit-0.36-0.040.000.000.000.00-0.770.00
Selling, General and Administrative Excl. Other6.025.301.791.982.422.312.073.43
Research and Development0.880.420.440.510.580.480.231.35
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.38-5.34-1.79-1.98-2.42-2.31-2.84-3.43
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-6.38-5.32-1.73-1.85-2.18-2.19-2.75-3.32
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-6.38-5.32-1.73-1.85-2.18-2.19-2.75-3.32
Net Income From Continuing Operations-6.38-5.32-1.73-1.85-2.24-2.07-2.64-3.23
Net Income-6.38-5.32-1.73-1.85-2.24-2.07-2.64-3.23
EPS (Recurring) per share-0.01-0.01-0.00-0.00-0.00-0.00-0.01-0.01
EPS (Basic, Before Extraordinaries) per share-0.01-0.01-0.00-0.00-0.00-0.00-0.01-0.01
EPS (Diluted) per share-0.01-0.01-0.00-0.00-0.00-0.00-0.01-0.01
EBITDA-6.02-5.30--1.98--2.31-2.07-3.43
Non-Operating Income (Expense)4E-050.020.060.120.250.130.100.11
Stock Option Compensation Expense1.591.64-0.280.210.320.210.82
Shares Outstanding million shares495.88494.49494.49494.49494.49494.49494.49494.49
Market Capitalization2,541.4110,384.278,426.091.691.153.607.899.55

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026FY6/30/20262025FY6/30/20252024FY6/30/20242023FY6/30/20232022FY6/30/20222021FY6/30/20212020FY6/30/20202019FY6/30/2019
Cash & Short Term Investments14.19+189.6%4.90-38.4%7.96-31.1%11.56-29.6%16.42+27266.7%0.06-84.6%0.39+62.5%0.24
Short Term Receivables0.000.000.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets0.03+200.0%0.01-93.3%0.15+150.0%0.06+100.0%0.03+200.0%0.010.000.00
Total Current Assets14.22+190.2%4.90-39.6%8.11-30.2%11.62-29.3%16.44+23385.7%0.07-82.1%0.39+62.5%0.24
Net Property, Plant & Equipment0.43-43.4%0.76+230.4%0.23-74.2%0.89-39.0%1.46+1725.0%0.08-27.3%0.110.00
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.00--0.00
Other Assets0.08-11.1%0.09-10.0%0.10-9.1%0.110.0%0.11-42.1%0.19+850.0%0.020.00
Total Assets14.73+155.7%5.76-31.8%8.44-33.1%12.62-30.0%18.02+5200.0%0.34-33.3%0.51+112.5%0.24
Short Term Debt Incl. Current Port. of LT Debt0.24-22.6%0.31+416.7%0.06-86.4%0.44+7.3%0.410.000.000.00
Accounts Payable0.000.000.000.000.000.000.000.00
Other Current Liabilities1.08+208.6%0.35+169.2%0.13-23.5%0.170.0%0.17-96.1%4.34+37.3%3.16+51.9%2.08
Total Current Liabilities1.32+100.0%0.66+247.4%0.19-68.9%0.61+5.2%0.58-86.6%4.34+37.3%3.16+51.9%2.08
Long Term Debt0.06-73.9%0.23+666.7%0.030.0%0.03-91.7%0.360.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities1.38+53.3%0.90+309.1%0.22-65.1%0.63-33.0%0.94-78.3%4.34+37.3%3.16+51.9%2.08
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity13.35+174.7%4.86-40.9%8.22-31.7%12.03-29.5%17.07-4.00-2.65-1.84
Total Shareholders Equity13.35+174.7%4.86-40.9%8.22-31.7%12.03-29.5%17.07-4.00-2.65-1.84
Accumulated Minority Interest0.000.000.00-0.04-300.0%0.020.000.000.00
Total Equity13.35+174.7%4.86-40.9%8.22-31.4%11.99-29.8%17.08-4.00-2.65-1.84
Total Liabilities & Stockholders Equity14.73+155.7%5.76-31.8%8.44-33.1%12.62-30.0%18.02+5200.0%0.34-33.3%0.51+112.5%0.24
Book Value Per Share per share0.03+200.0%0.01-50.0%0.020.0%0.02-33.3%0.03-0.01-0.01-0.00
Tangible Book Value Per Share per share0.03+200.0%0.01-50.0%0.020.0%0.02-33.3%0.03-0.01-0.01-0.00
Full-Time Employees people100.0%10-16.7%120.0%12-7.7%130.0%13+85.7%7-
Price to Book Ratio ratio190.3833.020.110.660.69---
Return on Assets %-114.25-50.50-40.85-38.32-82.73-315.34-214.54-
Return on Equity %-128.52-54.81-42.49-40.36-116.23---
Return on Invested Capital %-87.27-70.39-52.18-48.70-43.58---
Quick Ratio ratio10.777.3941.9219.1528.460.020.120.12
Current Ratio ratio10.777.3941.9219.1528.460.020.120.12

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2026FY6/30/20262025FY6/30/20252024FY6/30/20242023FY6/30/20232022FY6/30/20222021FY6/30/20212020FY6/30/20202019FY6/30/2019
Net Income--11.70-3.58-4.36-6.06-7.59-1.35-0.81-0.39
Depreciation-0.40+2.6%0.39-48.0%0.75-2.6%0.77+28.3%0.60+1900.0%0.03+200.0%0.010.00
Other Funds (Non Cash)-3.20+5233.3%0.06-70.0%0.20-76.2%0.84-69.5%2.75---
Funds from Operations--8.09-3.13-3.42-4.45-4.24-1.32-0.80-0.39
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital-0.40+1900.0%0.02-0.59-0.51-1.02-285.5%0.55+587.5%0.080.00
Cash from Operating Activities-7.70-7.70-3.11-4.00-4.96-5.27-0.77-0.73-0.39
Capital Expenditures0.000.00-0.15-0.01-0.03-0.780.00-0.120.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments2.502.50-12.0%2.84-45.9%5.25+5733.3%0.09-10.000.000.000.00
Purchase of Investments0.000.00-32.48-5.00-10.00-10.000.000.000.00
Sale Or Maturity of Investments2.502.50-92.9%35.32+244.6%10.25+1.6%10.090.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities2.502.50-7.1%2.69-48.7%5.24+8633.3%0.06-10.780.00-0.120.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock16.9516.950.000.000.00-100.0%22.670.000.000.00
Repurchase of Common Pref Stock-1.78-1.780.000.000.000.000.000.000.00
Sale of Common Pref Stock18.7218.720.000.000.00-100.0%22.670.000.000.00
Proceedsfrom Stock Options18.6218.620.000.000.00-100.0%22.670.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-100.0%0.10-23.1%0.13-0.27-161.4%0.44-55.6%0.99+106.3%0.48
Other Financing Activities Uses0.000.000.000.000.00-0.43-0.170.000.00
Cash from Financing Activities16.9516.950.00-100.0%0.10-23.1%0.13-99.4%22.41+4993.2%0.44-55.6%0.99+106.3%0.48
Exchange Rate Effect0.020.02-0.11-320.0%0.05-0.08----
Net Change in Cash11.7711.77-0.54-138.6%1.40-4.85-176.3%6.36-0.33-335.7%0.14+55.6%0.09
Free Cash Flow-7.70-7.70-3.27-4.01-4.99-6.05-0.77-0.84-0.39
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026S26/30/20262026S112/31/20252025S26/30/20252025S112/31/20242024S26/30/20242024S112/31/20232023S26/30/20232023S112/31/2022
Cash & Short Term Investments14.192.364.90-7.96-11.560.00
Short Term Receivables0.000.000.00-0.00-0.000.00
Inventories0.000.000.00-0.00-0.000.00
Other Current Assets0.030.000.01-0.15-0.060.00
Total Current Assets14.222.364.906.598.119.8311.6214.19
Net Property, Plant & Equipment0.430.560.760.000.230.000.890.00
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.00-0.00-0.00-
Other Assets0.080.090.090.890.100.640.111.36
Total Assets14.733.015.767.488.4410.4812.6215.55
Short Term Debt Incl. Current Port. of LT Debt0.240.260.310.000.060.000.440.00
Accounts Payable0.000.000.000.000.000.000.000.00
Other Current Liabilities1.081.410.350.000.130.000.170.00
Total Current Liabilities1.321.670.660.000.190.000.610.00
Long Term Debt0.060.130.230.000.030.000.030.00
Other Liabilities0.000.000.000.760.000.310.000.87
Total Liabilities1.381.790.900.760.220.310.630.87
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity13.351.224.866.728.2210.1612.0314.67
Total Shareholders Equity13.351.224.866.728.2210.1612.0314.67
Accumulated Minority Interest0.000.000.000.000.000.00-0.040.00
Total Equity13.351.224.866.728.2210.1611.9914.67
Total Liabilities & Stockholders Equity14.733.015.767.488.4410.4812.6215.55
Book Value Per Share per share0.030.000.010.010.020.020.020.03
Tangible Book Value Per Share per share0.030.000.010.010.020.020.020.03
Price to Book Ratio ratio190.382,136.3233.020.210.110.300.660.56
Return on Assets %-114.25-134.35-50.50-45.55-40.85-36.20-38.32-
Return on Equity %-128.52-177.66-54.81-48.45-42.49-37.93-40.36-
Return on Invested Capital %-47.61-394.64-33.99-27.60-27.11-20.34-21.93-21.99
Quick Ratio ratio10.771.427.39-41.92-19.15-
Current Ratio ratio10.771.427.39-41.92-19.15-

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026S26/30/20262026S112/31/20252025S22025S12024S22024S12023S22023S1
Cash from Operating Activities-5.10-2.59------
Capital Expenditures0.000.00------
Net Assets From Acquisitions0.000.00------
Sale of Fixed Assets and Businesses0.000.00------
Purchase or Sale of Investments0.002.50------
Purchase of Investments0.000.00------
Sale Or Maturity of Investments0.002.50------
Other Uses0.000.00------
Other Sources0.000.00------
Cash from Investing Activities0.002.50------
Cash Dividends Paid0.000.00------
Preferred Dividends (Cash Flow)0.000.00------
Change in Capital Stock16.950.00------
Repurchase of Common Pref Stock-1.780.00------
Sale of Common Pref Stock18.720.00------
Proceedsfrom Stock Options18.620.00------
Issuance or Reduction of Debt, Net0.000.00------
Change in Long Term Debt0.000.00------
Issuance of Long Term Debt0.000.00------
Reduction of Long Term Debt0.000.00------
Net Financing Active Other Cash Flow0.000.00------
Other Financing Activities Uses0.000.00------
Cash from Financing Activities16.950.00------
Exchange Rate Effect-0.010.03------
Net Change in Cash11.84-0.06------
Free Cash Flow-5.10-2.59------

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.62%0.3M56.2M249.12K
2026-10-150.78%0.4M56.2M224.23K
2026-09-301.17%0.7M56.1M279.51K
2026-09-151.43%0.8M56.1M327.97K
2026-08-311.70%1.0M56.1M298.67K
2026-08-141.77%1.0M56.1M297.98K
2026-07-311.61%0.9M56.1M282.12K
2026-07-151.66%0.9M56.1M260.47K
2026-06-301.36%0.8M56.1M167.24K
2026-06-151.34%0.8M56.1M129.48K
2026-05-291.39%0.8M56.1M132.59K
2026-05-151.42%0.8M56.0M133.74K
2026-04-301.38%0.8M56.0M143.29K
2026-04-151.48%0.8M56.0M218.08K
2026-03-311.24%0.7M56.6M409.54K
2026-03-131.07%0.6M56.6M451.13K
2026-02-271.12%0.6M56.6M475.67K
2026-02-131.19%0.7M56.6M479.08K
2026-01-301.37%0.8M56.6M472.62K
2026-01-151.63%0.9M56.6M398.48K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.404.905.002544.0%1.000.000.959-0.0140.001
call5.000.001.552.55514.8%36.000.000.722-0.1250.003
call7.500.050.200.10262.6%18813.000.213-0.0370.002
call10.000.001.000.05396.3%2360.000.195-0.0520.002
call12.500.000.750.05473.6%55.000.000.174-0.0580.002
call15.000.004.900.05532.4%2150.000.162-0.0630.002
call17.500.004.900.00580.1%0.000.000.154-0.0660.002
call20.000.000.050.05607.5%1260.000.147-0.0670.002
put2.500.000.050.00-0.000.00-0.018-0.0540.000
put5.000.152.500.41934.9%1060.00-0.278-0.1240.003
put7.500.504.901.691091.2%7.000.00-0.759-0.0420.002
put10.002.507.104.001100.1%34.000.00-0.805-0.0510.002
put12.505.009.600.001186.9%0.000.00-0.826-0.0570.002
put15.007.5012.200.001288.8%0.000.00-0.838-0.0610.002
put17.5010.0014.600.001306.8%0.000.00-0.846-0.0640.002
put20.0012.5017.100.001352.3%0.000.00-0.956-0.0180.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-0720-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2026-06-30SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-22SEC
2026-05-19424B5SEC
2026-05-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-19SEC
2026-05-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-19SEC
2026-05-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-31SEC
2026-04-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-17SEC
2026-03-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-30SEC
2026-03-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-30SEC
2026-03-30424B5SEC
2026-03-30F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-02-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-13SEC
2025-10-3120-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-06-30SEC
2025-07-11SCHEDULE 13D/ASEC
2025-06-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-30SEC
2025-06-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-30SEC
2025-06-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-17SEC
2025-06-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-02SEC
2025-03-13SCHEDULE 13D/ASEC
2025-01-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-01-15SEC
2024-10-2520-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2024-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
GEODE CAPITAL MANAGEMENT, LLC0.09%
Alyeska Investment Group, L.P.0.08%
Legal & General Group Plc0.03%
JANE STREET GROUP, LLC0.02%
XTX Topco Ltd0.01%
Amundi0.01%
Quadrature Capital Ltd0.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.00%
Squarepoint Ops LLC0.00%
FOX RUN MANAGEMENT, L.L.C.0.00%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.06%
Fidelity Nasdaq Composite Index ETF0.02%
State Street(R) SPDR(R) S&P(R) China ETF0.00%
BNY Mellon International Equity ETF0.00%
Goldman Sachs MarketBeta International Equity ETF0.00%
Goldman Sachs MarketBeta Total International Equity ETF0.00%
Invesco S&P Emerging Markets Momentum ETF0.00%

OakChart. RGC. Cached 15 minutes. Terms

Some panels did not load: ratings, insider.